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ARTICLE
First Reported Patient with Human ERCC1 Deﬁciency Has
Cerebro-Oculo-Facio-Skeletal Syndrome with a Mild Defect in
Nucleotide Excision Repair and Severe Developmental Failure
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Andria Rasile Robinson, Giuseppina Giglia-Mari, Deborah Hoogstraten, Wim J. Kleijer,
Jan H. J. Hoeijmakers, and Wim Vermeulen
Nucleotide excision repair (NER) is a genome caretaker mechanism responsible for removing helix-distortingDNA lesions,
most notably ultraviolet photodimers. Inherited defects in NER result in profound photosensitivity and the cancer-prone
syndrome xeroderma pigmentosum (XP) or two progeroid syndromes: Cockayne and trichothiodystrophy syndromes.
The heterodimer ERCC1-XPF is one of two endonucleases required for NER. Mutations in XPF are associated with mild
XP and rarely with progeria. Mutations in ERCC1 have not been reported. Here, we describe the ﬁrst case of human
inherited ERCC1 deﬁciency. Patient cells showed moderate hypersensitivity to ultraviolet rays and mitomycin C, yet the
clinical features were very severe and, unexpectedly, were compatible with a diagnosis of cerebro-oculo-facio-skeletal
syndrome. This discovery represents a novel complementation group of patients with defective NER. Further, the clinical
severity, coupled with a relatively mild repair defect, suggests novel functions for ERCC1.
From the Departments of Genetics (N.G.J.J.; A.R.; N.W.; G.G.-M.; D.H.; J.H.J.H.;W.V.) and Clinical Genetics (W.J.K.), ErasmusMedicalCenter, Rotterdam,
The Netherlands; Department of Pediatrics, University of Torino, Torino, Italy (M.C.S.); and Department of Molecular Genetics and Biochemistry,
University of Pittsburgh Cancer Institute, Pittsburgh (L.J.N.; A.R.R.)
Received October 20, 2006; accepted for publication January 5, 2007; electronically published January 29, 2007.
Address for correspondence and reprints: Dr. Nicolaas G. J. Jaspers, Department of Genetics, ErasmusMedical Center, P.O. Box 2040, 3000CARotterdam,
The Netherlands. E-mail: n.jaspers@erasmusmc.nl
Am. J. Hum. Genet. 2007;80:457–466.  2007 by The American Society of Human Genetics. All rights reserved. 0002-9297/2007/8003-0007$15.00
DOI: 10.1086/512486
Helix-distorting DNA lesions, such as those produced by
UV light, are repaired by nucleotide excision repair (NER),
a multistep cut-and-paste mechanism requiring 130 pro-
teins.1 Helical distortion is recognized throughout the ge-
nome by the protein complexes XPC-HR23B and DDB. As
an alternative to this global-genome NER (GG-NER), DNA
damage blocking RNApol II progression on transcribed
strands is rapidly repaired by transcription-coupled NER
(TC-NER). This subpathway of NER speciﬁcally requires
CSA, CSB, and UVS proteins. Once the damage is recog-
nized, the repair reactions for GG-NER and TC-NER are
identical. The helix is locally unwound by the TFIIH com-
plex and bound by XPA and RPA proteins, which ensure
correct positioning of two endonucleases, ERCC1-XPF and
XPG. These enzymes incise the damaged strand on either
side of the lesion, to remove the damaged oligonucleotide
and to allow resynthesis and restoration of the phosphate
backbone by DNA polymerase and ligase.
Among patients with defective NER, 11 genetic com-
plementation groups are known.2 Defects in GG-NER
cause the cancer-prone syndrome xeroderma pigmento-
sum (XP [MIM 278700, MIM 610651, MIM 278720, MIM
278730, MIM 278740, MIM 278760, MIM 278780, and
MIM 133530]), characterized by severe photosensitivity;
a 1,000-fold increased risk of skin cancer, which appears
as early as the 1st decade of life; a 10-fold increased risk
of other tumors; and, in severe cases, neurodegeneration.2
Selective impairment of TC-NER, due to mutation of CSA
or CSB, causes Cockayne syndrome (CS [MIM 133540 and
MIM 216400]), characterized by UV-sensitivity—but not
cancer—cachectic dwarﬁsm, and progeroid symptoms, in-
cluding profound neurodegeneration.2 Several of the NER
proteins have functions distinct from NER, leading to
complex and pleiomorphic disease phenotypes. A notable
example is TFIIH, which is essential for bothNER andbasal
transcription. Speciﬁc hypomorphic mutations in various
subunits of TFIIH (XPB, XPD, and TFB5/TTD-A), give rise
to a heterogeneous syndrome, trichothiodystrophy (TTD
[MIM 601675]), characterized by photosensitivity andhair
and skin abnormalities.3–5 The developmental and degen-
erative features of TTD and CS are attributed to reduced
transcriptional capacity rather than defective DNA repair.4
ERCC1-XPF is a structure-speciﬁc endonuclease that
is required to incise the damaged strand of DNA 5′ to
the lesion.6 In addition, the heteroduplex participates in
the repair of DNA interstrand crosslinks7,8 through a
mechanism distinct from NER.9 In yeast and Drosophila,
ERCC1-XPF orthologs participate in meiotic and mitotic
recombination, including homology-mediated DNA dou-
ble-strand break repair.10–13 In mammals, the heterodimer
is essential for homology-dependent gene targeting in
hamster14 and mouse embryonic stem cells,15 but its phys-
iological role in recombination is not known. ERCC1-XPF
is also associated with telomeres, where it modulates re-
combination of telomeric sequences and loss of telomeres
from deprotected chromosome ends.16,17 Numerous re-
ports have suggested ERCC1 expression in tumors as a
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Figure 1. Characteristics of patient 165TOR and Ercc1/ mice.
A, Image of patient at birth. B, Arthrogryposis of hands and rocker-
bottom feet and frontal face appearance. Note microcephaly. C and
D, Nuclear magnetic resonance scans of head, demonstrating sim-
pliﬁed gyral pattern and cerebellar hypoplasia. E, Hematoxylin-
eosin stained sections of 1-d-old mice (top row) and 4-d-old mice
(bottom row), demonstrating delayed development of Ercc1/
mouse cerebellum (including hypoplasia and blunted gyri) com-
pared with that of wild-type (WT) littermates. Images are repre-
sentative of those obtained for at least three mice of each
genotype.
predictor of DNA-crosslinker–based chemotherapy efﬁ-
cacy (for review, see work of Reed18).
Despite the involvement of ERCC1-XPF in multiple ge-
nome maintenance mechanisms, patients with defective
XPF typically display only very mild XP, rarely developing
skin tumors before adulthood.19,20 In all cases, the muta-
tions are hypomorphic and cause signiﬁcant residual pro-
tein and NER. Although ERCC1 (MIM 126380) was the
ﬁrst mammalian repair gene to be cloned21 and targeted
in mice,22 not a single case of an ERCC1 defect has been
identiﬁed, despite exhaustive screens in photosensitive
patients for 3 decades. Here, we describe the very ﬁrst case
of human ERCC1 deﬁciency. Unexpectedly, the patient
displayed a relatively mild impairment of NER, similar to
that seen in XPF cases, but very severe symptoms, includ-




Patient 165TOR was born from nonconsanguineous Italianwhite
parents, after a 37-wk pregnancy complicated by intrauterine
growth retardation. Amniocyte analysis did not reveal any kar-
yotypic abnormality. At birth, the patient’s weight, length, and
occipitofrontal circumference were !3rd percentile. The infant
had microcephaly (ﬁg. 1A and 1B) with premature closure of fon-
tanels, bilateral microphthalmia, blepharophimosis, high nasal
bridge, short ﬁltrum, micrognathia, low-set and posterior-rotated
ears (ﬁg. 1A), arthrogryposis with rocker-bottom feet (ﬁg. 1B),
ﬂexion contractures of the hands (ﬁg. 1B), and bilateral congen-
ital hip dislocation. On x-rays, there was no evidence for spine
abnormalities. Nuclear magnetic resonance (ﬁg. 1C and 1D) re-
vealed a simpliﬁed gyral pattern and cerebellar hypoplasia. There
was mild hypoplasia of the kidneys, with normal structure and
function. Echography did not reveal any congenital heart defects.
These combined symptoms were compatible with a clinical di-
agnosis of a severe form of cerebro-oculo-facial-skeletal syndrome
(COFS [MIM 214150]). In the differential diagnosis, other dys-
morphology syndromes, such as Warburg Micro syndrome (MIM
600118) and CS type II, were considered. Because of the absence
of genital abnormalities and retinopathy, COFS was the preferred
diagnosis, with the caveat that a deﬁnitive diagnosis for these
progressive disorders is hard to make in an infant.
The child showed failure to thrive, was tube fed, and did not
pass any developmental milestone. Respiratory failure due to bi-
lateral pneumonia was the cause of death at age 14 mo. Weight
was 4.5 kg, height was 56 cm, and occipitofrontal circumference
was 38 cm, at the time of death. A postmortem study was not
performed.
Cell Cultures
Dermal ﬁbroblasts were grown in Ham’s F10 medium (without
thymidine) containing 15% fetal bovine serum and antibiotics.
Cell strains 165TOR, 173TOR, and 174TOR were obtained from
the proband, his father, and his mother, respectively. Other NER-
deﬁcient standard strains and their defective genes (HUGOname,
best-known alias) are XP25RO (XPA [MIM 278700]), XP131MA
(ERCC3, XPB [MIM 610651]), XP21RO (XPC [MIM 278720]),
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XP6BE (ERCC2, XPD [MIM 278730]), XP42RO and XP51RO (both
ERCC4, XPF [MIM 278760]), XPCS1RO and XP3BR (both ERCC5,
XPG [MIM 133530]), CS3BE (ERCC8, CSB [MIM 133540]), CS1AN
(ERCC6, CSA [MIM 216400]), TTD1BR (GTF2H5 [MIM 608780],
TTDA), and Kps3 (UVS [MIM 600630]). XPF patient strain
XP51RO is the same as the one called “XFE” elsewhere.23 NER
deﬁciency of embryonic ﬁbroblasts derived from Ercc1/ mice
was described elsewhere.24 Chinese hamster CHO mutant cells
43-3B,25 transfectant cells, and normal AA8 or CHO9 cells were
cultured in HamF10 and Dulbecco’s modiﬁed Eagle medium (1:
1) plus 10% serum.
Preloading of human ﬁbroblasts with cytoplasmic beads was
performed as described elsewhere.4,26 In short, subconﬂuent cul-
tures were kept in the presence of polystyrene microspheres of
either 0.8 or 2.2 mM for 3 d. Cultures were trypsinized, extensively
washed,mixed, and seeded for use in other proceduresmentioned
below.
UV Exposures and Repair Assays
UV light of predominantly 254 nmwas emitted from a germicidal
low-pressure mercury lamp, at a ﬂuence of 0.6 W/m2. Local ex-
posure of subcellular areas through Millipore ﬁlters was done as
described elsewhere.27 For global genome NER activity, unsched-
uled DNA synthesis (UDS) was measured by exposure of coverslip
cultures to 16 J/m2 of UV light and subsequent incubation for 3
h in medium containing 10 mCi/mL [3H-1′,2′]-thymidine (120Ci/
mmol [Amersham TRK565]). Cells were ﬁxed, coverslips were
dipped in Ilford K2 photographic emulsion, and slides were de-
veloped after 3 d of exposure and were stained with Giemsa.
Nuclear silver grains were counted in 50 cells. TC-NER was mea-
sured as the ability to recover from UV-induced inhibition of
transcription. After 16 h of exposure to 16 J/m2 of UV, cells were
cultured for 1 h in medium containing [3H-5′,6′]-uridine (40 Ci/
mmol [Amersham TRK410]) and were processed for autoradiog-
raphy as described above. Survival of ﬁbroblasts (exposed to UV)
and Chinese hamster cells (exposed to UV andmitomycin C) was
measured as described elsewhere,28 by exposing 48-h-old sparse
cultures to graded UV or mitomycin C doses. After further growth
for 3–4 d, cells were labeled for 1–3 h in medium containing
2.5 mCi/ml [methyl-3H]-thymidine (50 Ci/mmol [Amersham
TRK418]), were chased for 1 h, were lysed in 0.25-M NaOH, and
were scintillation counted. Fibroblasts’ colony-forming ability (af-
ter mitomycin C) was measured by seeding ﬁbroblasts on 24-h-
old thin ﬁbroblast feeder layers (exposed to 40 Gy of gamma-
rays) and by counting the colonies after 13–18 d.
Complementation Analysis and Sequencing
For classical complementation analysis of mutant human ﬁbro-
blasts,29 two ﬁbroblast strains were preloaded with distinct types
of cytoplasmic beads, mixed 1:1 and fused using inactivated Sen-
dai virus. At 24–48 h after reseeding and attachment, these cul-
tures, containing a mixture of unfused cells and fused multikar-
yons, were exposed to UV and were assayed for GG-NER and
TC-NER activities. In the slides, hetero- and homokaryons were
distiniguished on the basis of the beads.
For sequencing, total RNA was isolated from the patient ﬁbro-
blasts and was reverse transcribed using random hexamer prim-
ers. ERCC1 was ampliﬁed in two overlapping fragments from the
cDNA and was directly sequenced by standard protocols and after
cloning. Coding stretches of ERCC1 were also ampliﬁed from ﬁ-
broblast genomic DNA by use of exon-speciﬁc primers and were
sequenced.
Microinjection
Procedures for microinjection were as described elsewhere.30 Be-
fore seeding was done, ﬁbroblast fusion was induced using in-
activated Sendai virus, to generate scattered multikaryons. In
3-d-old cultures, recognizable multikaryons were microinjected
with concentrated proteins (in the cytoplasm) or with cDNA-
expression vector (in one of the nuclei). At 24–48h after injection,
UDS was assayed in the cultures as described above.
Immunodetection
Expression of XPF and ERCC1 proteins was detected by immu-
noblotting 10 mg of crude cell extracts from human ﬁbroblasts
and CHO cells, as well as by immunoﬂuorescence of parafor-
maldehyde-ﬁxed cultures, by use of mouse monoclonal anti-
hXPF (1:1,000) and afﬁnity-puriﬁed rabbit polyclonal anti-
hERCC1 antibodies.31 The latter detects the human protein
only. Rabbit anti-XPC (1:500),32 mouse anti-p62 (3C7) (donated
by J. M. Egly) (1:2,000), and anti-XPA27 (1:500) were used for
immunoﬂuorescence.
Mouse Histology
Ercc1/ and wild-type littermates were bred from heterozygous
crossings in a mixed (C57Bl/6:FVB/n) genetic background. Mice
were euthanized by decapitation on postnatal day 1 or 4. Heads
were ﬁxed in neutral buffered saline containing 20% sucrose for
48 h, were embedded in parafﬁn, were sectioned, and were
stained with hematoxylin and eosin. Cerebellar sections from
three mice of each genotype were examined at each time point.
Genomic DNA was isolated from tissue of each pup for PCR-based
genotyping.
Results
A Defective NER Core Factor in 165TOR
Since some patients with COFS were described as having
defective NER caused bymutations in ERCC6/CSB, ERCC2/
XPD, or ERCC5/XPG,33–35 we assessed NER in the skin ﬁ-
broblasts of the patient (165TOR). UV-induced UDS, a
measure of GG-NER activity, was reduced to 15% of nor-
mal (ﬁg. 2A and 2C). RNA synthesis recovery after UV
exposure, a measure of TC-NER, was reduced to 13% of
normal, which, while low, was not as severe as in cells
from a patient with CS-B or a patient with XP from com-
plementation group A (XP-A) (ﬁg. 2B and 2C). Similarly,
the patient’s cells were fourfold more sensitive to UV than
were normal ﬁbroblasts (ﬁg. 2D), which is intermediate
compared with XP-A (10# hypersensitive) and is similar
to XP-C cells, missing only GG-NER or CS-B cells, missing
only TC-NER. The compromise of both GG-NER and TC-
NER in 165TOR strongly implies that a core NER factor
(TFIIH, XPA, RPA, XPG, or XPF/ERCC1) is defective.
This NER defect was used for prenatal diagnosis in a
next at-risk pregnancy in the family, as described else-
where.34 A fully normal level of NER was observed in cul-
tured chorionic villus cells from the fetus (data not
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Figure 2. NER in 165TOR cells. A and B, Comparative autora-
diography of a mixed culture of normal C5RO (small cytoplasmic
beads) and 165TOR patient ﬁbroblasts (large beads). A, GG-NER
was measured as UDS by pulse labeling the cells with 3H-thymidine
after exposure to 16 J/m2 UV-C, as described elsewhere.20 B, TC-
NER was measured as RNA synthesis recovery (RSR) after UV by
pulse labeling the cells with 3H-uridine 16 h after they were ex-
posed to 16 J/m2 UV. C, Quantiﬁcation of UDS and RSR by counting
the silver grains in 50 nuclei of 165TOR (black) compared with in
normal cells on the same slide. Data are shown in comparison with
XP-A, XP-C, and CS-B standard strains measured in separate ex-
periments. D, Cell survival assay to measure UV sensitivity of
165TOR (dots) relative to that of normal (C5RO), XP-A (diamonds),
XP-C (unblackened circles), and CS-B (crosses) standard strains. E
and F, Immunoﬂuorescence detection of NER proteins to sites of
UV-induced DNA damage. 165TOR cells were exposed to local UV
radiation as described elsewhere,27 were ﬁxed after 1 h, and were
stained with antibodies against TFIIH core component p62 and
XPC (E) or with anti-XPA antibodies (F).
shown), and a healthy child was born after an uneventful
pregnancy.
Patient 165TOR, Representing a Novel NER
Complementation Group
In an attempt to identify the defective NER factor, genetic
complementation was performed by somatic cell fusion
of the patient cells with a well-deﬁned panel of cells from
patients with defective NER. All the strains tested were
able to fully complement the lowUV-inducedUDS or RNA
synthesis recovery of 165TOR (data not shown). The re-
sults excluded not only the three COFS candidate genes
but also XPA, XPC, and XPF; the recently identiﬁed gene
TTDA5; and the TC-NER factors CSA, CSB, and UVS. The
data demonstrate that this patient represents a new NER
complementation group and carries a recessive gene defect
that is distinct from those carried by all known patients
with defective NER.
Identiﬁcation of the Genetic Defect
Of the 10 subunits of TFIIH, only XPB, XPD, and TTDA
are linked with genetic diseases. Since an XPD mutation
has been associated with severe COFS,34 we next consid-
ered the other subunits of TFIIH as candidates. The TFIIH
complex, puriﬁed from HeLa cells, was microinjected into
165TOR homokaryons, and UV-induced UDS was mea-
sured. TFIIH corrected the XPB cells but not the 165TOR
cells (data not shown). We concluded that the patient’s
NER defect was not caused by a defect in any of the TFIIH
subunits.
Since the steps of NER are well deﬁned,36 it is possible
to functionally map the NER defect in 165TOR cells by
use of immunoﬂuorescence. Sequential recruitment of
NER proteins XPC, XPA, and TFIIH to subnuclear domains
of local UV damage27 was found to be undisturbed in
165TOR cells (ﬁg. 2E and 2F). So, the defect in 165TOR
cells is at a late stage of NER, which leaves RPA, ERCC1,
and DNA replication factors as candidate genes.
To test these possibilities, 165TOR cells were microin-
jected with recombinant ERCC1-XPF or with RPA heter-
otrimer. The latter failed to correct the low UV-induced
UDS in 165TOR cells (not shown). In contrast, puriﬁed
ERCC1-XPF protein (ﬁg. 3A) as well as ERCC1 cDNA (ﬁg.
3B) did correct UDS. ERCC1 cDNA is known not to correct
any other NER complementation group,37,38 and two in-
dependent XP-F cell lines fully complement 165TOR, so
these results strongly implicate ERCC1 as the gene affected
in 165TOR.
We next sequenced both the ERCC1 cDNA and genomic
locus from cells from the patient (165TOR) and his par-
ents. This revealed two point mutations in the coding
region of ERCC1 (ﬁg. 3E) and no abnormalities in the
splice signals of all nine introns. A CrT transition pre-
dicted to convert codon Gln158 into an amber translational
stop signal was inherited from the mother (ﬁg. 3C). The
truncated polypeptide encoded by this allele lacks the en-
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Figure 3. ERCC1 defect in patient 165TOR. A and B, UV-induced
UDS measured after microinjection of puriﬁed ERCC1-XPF protein
complex (A) or ERCC1-GFP expression vector (B) into 165TOR mul-
tikaryons (arrows). Note the low number of grains in single cells
from the same patient that were not injected. C and D, Partial
genomic sequences of ERCC1 exon 5 (Q158X) and exon 7 (F231L).
The presence of Q158X was veriﬁed by restriction analysis of the
destroyed PstI site (boxed). E, Schematic diagram of ERCC1, in-
dicating exons (Roman numerals), known protein domains (XPA
and XPF binding domain [BD] and helix-hairpin-helix [HLH] DNA
binding motifs), and the inactivating mutations found in patient
165TOR (red-shaded boxes). The mutation identiﬁed in 43-3B CHO
cells, which have undetectable levels of ERCC1-XPF, is also indi-
cated (blue-shaded box). F and G, Fusion of mouse Ercc1/ em-
bryonic ﬁbroblasts with human ﬁbroblasts (165TOR [F] and XPB
[G]), followed by UDS assay. Note noncomplementation in panel
E and complementation in panel G. Heterokaryons were identiﬁed
on the basis of cytoplasmic beads as well as by nucleolar
morphology.
Table 1. Conservation of Phenylalanine at
Position 231 in ERCC1
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
tire C-terminal domain, which is essential for interaction
with XPF.39 Heterodimerization of ERCC1-XPF is required
for complex stability and endonuclease activity.6,40–42
Therefore, this Q158amber allele is expected to be a func-
tional null. The paternal allele carried a CrG transversion
predicted to change Phe231 to a leucine (ﬁg. 3D), a se-
quence variant not described in the public SNP database
(NCBI: SNPs Linked to Gene ERCC1). This residue lies
within the XPF binding domain of ERCC1 and is fully
conserved among mammals and in Xenopus laevis. Fish,
plants, and yeast or fungi have physicochemically similar
aromatic tyrosine residues at this position, whereas insects
have proline. In none of the sequences from 38 widely
divergent species was a leucine or leucine-like amino acid
(valine, isoleucine, alanine, or methionine) found there
(table 1), although these residues together represent al-
most 30% of the available codons. Both mutated mRNAs
were normally expressed, and the parents are both het-
erozygous for their respective mutations.
Low Levels of ERCC1-XPF Heterodimer in 165TOR
To determine whether these mutations affected the level
of ERCC1 protein in 165TOR cells, we used comparative
immunoﬂuorescence, by labeling normal ﬁbroblasts with
cytoplasmic beads and then coculturing them with
165TOR cells before immunodetection of ERCC1.43 In
comparison with normal and parent ﬁbroblasts, 165TOR
cells had signiﬁcantly reduced levels of ERCC1 in the nu-
cleus, with concomitant intense immunoreactivity in the
cytoplasm (ﬁg. 4A and 4C). Nuclear XPF was similarly re-
duced, but cytoplasmic staining was not apparent (ﬁg. 4B).
The average ﬂuorescence intensities of ERCC1 and XPF
were estimated at 15% and 30% of neighboring normal
ﬁbroblasts, respectively. These results were conﬁrmed by
immunoblotting (ﬁg. 4E and 4F), yielding 14% and 20%.
With this antibody,41 truncated protein from theQ158 allele
was not readily detected on immunoblot. Cytoplasmic
ERCC1 immunoreactivity was also observed in cells from
the mother only, who carries the Q158X allele (ﬁg. 4F and
4G). ERCC1 levels in 165TOR cells were comparable to a
typical XP-F patient with mild XP and very late neuro-
degeneration (XP42RO)20 and a unique XP-F patient with
juvenile progeroid symptoms (XP51RO)23; remarkably,
XPF levels were somewhat higher in 165TOR cells (for
immunoblot, see ﬁg. 4C and 4D; comparative immuno-
ﬂuorescence data not shown). The residual level of ERCC1-
XPF in each of these cell lines is predictive of moderate
sensitivities to UV and the crosslinking agent mitomycin
C (165TOR: 4#UV and 2–3#mitomycin C; XP51RO: 5#
UV and mitomycin C; ﬁg. 5A).23 Together, these data in-
dicate that the ERCC1 mutations observed in 165TOR
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Figure 4. ERCC1/XPF protein levels in the patient and his parents.
A and B, Comparative immunoﬂuorescence with anti-ERCC1 (A) or
anti-XPF (B) antibodies. Upper panels are mixed phase contrast
and 4′-6 diamidino-2-phenylindole images, to demonstrate the
presence of cytoplasmic beads in the normal control ﬁbroblasts
(C5RO), mixed 1:1 with 165TOR cells (which have no beads). Note
cytoplasmic pseudoﬂuorescence caused by the optic effects of
beads. C–E, Immunoblots with anti-ERCC1 (C and E) or anti-XPF
(D) on whole-cell extracts from C5RO (normal), two XP-F patient
cell lines (XP42RO(F) and XP51RO(F)), 165TOR, and the mother
and father of 165TOR. The relevant bands are indicated with arrows;
cross-reacting bands (indicated by an asterisk [*]) served as load-
ing controls. Note the presence of degraded ERCC1, speciﬁcally in
165TOR (C). F and G, Comparative immunodetection of ERCC1 on
cells from the parents, compared with 165TOR and normal. Mixed
cultures contained C5RO (large beads) and 165TOR cells.
cause reduced but not absent nuclear ERCC1-XPF and a
partial NER and crosslink-repair defect. In addition, loss
of the XPF-binding domain of ERCC1 prevents nuclear
localization of the protein.
Correcting Activities of the Two ERCC1 Alleles
To deﬁnitively demonstrate ERCC1’s involvement in the
NER defect, we fused 165TOR cells to cultured embryonic
ﬁbroblasts derived from Ercc1/ mice. In the heterokar-
yons, the ERCC1 F231L mRNA is expressed at physiological
levels and speciﬁes the only full-length ERCC1 species
available. UV-induced UDS was not complemented (ﬁg.
3F), whereas NER was fully restored by fusion of NER-
defective human XPB with mouse Ercc1/ ﬁbroblasts (ﬁg.
3G). In addition, we cloned and expressed both mutant
human cDNAs in Chinese hamster 43-3B cells. These cells
harbor a V98E point mutation in Ercc1 (ﬁg. 3E),44 which
results in undetectable levels of the protein and its binding
partner XPF.41 CHO transfectants typically carry numerous
copies of their transgene, resulting in strong overexpres-
sion.21,38 XPF protein levels were restored in 43-3B cells
expressingwild-type ERCC1 or ERCC1-F231L cDNA (ﬁg. 5B).
Although the Q158X mutation causes truncation of ERCC1
before the XPF binding domain, overexpression of themu-
tant cDNA resulted in stabilization of XPF protein to a
limited extent (ﬁg. 5B). This was attributed to a low-level
read-through of the amber codon, resulting in a small
amount of full-length ERCC1 protein, bothwith andwith-
out a C-terminal green ﬂuorescent protein (GFP) tag (ﬁg.
5E), as a consequence of very high mRNA levels.
Expression of wild-type ERCC1 cDNA in 43-3B cells re-
sulted in near-complete correction of UV and mitomycin
C hypersensitivity (ﬁg. 5C and 5D). Stable expression of
ERCC1-F231L cDNA corrected UV and mitomycin C sen-
sitivity to a similar extent as in wild-type cells (ﬁg. 5C and
5D). This is consistent with a “leaky” mutation, in which
overexpression leads to complementation. A low but sig-
niﬁcant correction of UV sensitivity was also detected in
cells stably expressing the Q158 truncation mutation (ﬁg.
5B). Remarkably, the small amount of full-length ERCC1
generated from the nonsense allele was sufﬁcient to al-
most completely correct mitomycin C hypersensitivity of
the parental cell line (ﬁg. 5D). This supports previouswork
indicating that very low levels of ERCC1-XPF are sufﬁcient
for crosslinker resistance in CHO cells.45
Finally, to fulﬁl a formal requirement by this journal’s
editor, we checked the presence of ERCC1-F231L in a
matched human control population. Among 364 chro-
mosomes 19 tested, we found none.
Discussion
COFS Due to Unstable ERCC1-XPF
With the reservation that we describe only a single case
patient here, genetic and functional data support the con-
clusion that the severe congenital and developmental ab-
normalities in this patient were caused by biallelic mu-
tation of ERCC1. On the basis of the independent
functional analysis of each mutation, we conclude that
the Q158 mutation results in a null allele, whereas the
ERCC1 F231L, in combination with XPF, has enzymatic ac-
tivity. The clinical phenotype of the patient and the DNA
repair defect in 165TOR cells are a direct consequence of
low levels of ERCC1-XPF rather than loss of enzymatic
activity. This is analogous to patients withXP-F. In all cases
in which the mutations are well characterized, point mu-
tations are found, which occur outside of the essential
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Figure 5. Functionality of mutant ERCC1 cDNA. A, Clonogenic survival assay to measure sensitivity of ﬁbroblasts to the crosslinking
agent mitomycin C. 165TOR cells are compared with normal primary and human tert-immortalized ﬁbroblasts (C5RO(tert)). For panels
B–E, ERCC1-deﬁcient 43-3B cells were stably transfected with expression plasmids carrying human ERCC1 or human ERCC1-GFP driven
by a cytomegalovirus promoter and a neoR selection marker. G418-resistant mass populations were checked for survival after exposure
to UV (C) or mitomycin C (D), compared with untransfected 43-3B cells (blackened squares) and wild-type AA8 cells (unblackened
squares). Vectors were ERCC1 wild type (WT) (diamonds), ERCC1 F231L (triangles), and ERCC1 Q158X (circles). Blackened and unblackened
symbols represent ERCC1 and ERCC1-GFP constructs, respectively. B and E, Western blots of transfected mass populations by use of
antibodies against XPF (B) or ERCC1 (E). Cross-reacting bands (serving as loading controls) are indicated by an asterisk (*).
functional domains of XPF (i.e., the catalytic domain, the
helicase motifs, and the ERCC1-binding domain).23 Also,
in all cases, there is signiﬁcant residual repair activity
(15%–30%) and very moderate (2–3 times) UV sensi-
tivity.19,20 Remarkably, even though these mutations are
outside the protein interaction domain, both XPF and
ERCC1 levels are strongly reduced in ﬁbroblasts from each
of these XP-F patients (ﬁg. 4A and 4B).20,42 The CHO 43-
3B mutation V98E recapitulates this. Moreover, whereas
the N-terminal 92 aa of ERCC1 are dispensable for DNA
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repair,45 two missense mutations within the same domain
abolish repair and heterodimer expression.46 This absolute
concordance between point mutations in either ERCC1 or
XPF and the instability of the entire heteroduplex implies
that, in living cells, the stability of the heterodimer is un-
der strict regulation, likely via careful scrutiny of the con-
formation of the complex, which explains the difﬁculties
in its overproduction.47
Genotype-Phenotype Relationships of ERCC1-XPF Deﬁciency
This unique patient with mutated ERCC1 genes represents
the clinically severest case of NER deﬁciency described so
far and contrasts with the very mild symptoms of XP-F
patients, who may easily escape clinical diagnosis. Both
Ercc1 and Xpf have been genetically deleted in the mouse
resulting in seemingly identical phenotypes, includingde-
fective DNA repair, impaired intrauterine and postnatal
growth failure, life-limiting liver and kidney disease, and
early death.22,48–50 This phenotype, being much more se-
vere than that of Xpa/ mice, which are completely de-
ﬁcient in NER,51 underscores the importance of ERCC1-
XPF functions distinct from NER. The symptoms are
further complicated by neuronal dysfunction, such as cer-
ebellar ataxia in later life.23 Premature replicative senes-
cence of Ercc1/ primary ﬁbroblasts, hepatocytes, and
bone marrow progenitors are consistent with growth fail-
ure and has been attributed to an inability to repair en-
dogenous DNA damage.52 Furthermore, recent evidence
indicates that genotoxic stress or poor genome mainte-
nance causes suppression of the somatotroph axis, a self-
protective mechanism that focuses energy stores onmain-
tenance rather than on growth.23 The clinical course of
patient 165TOR bears striking resemblance to these
ERCC1-XPF–deﬁcient mice. Unfortunately, a postmortem
examination was not done, making it impossible to ex-
tend the comparison beyond clinical data. The simpliﬁed
gyral pattern and cerebellar hypoplasia seen in patient
165TOR, which were not previously described in patients
with defective NER, are indicative of postmitotic neuronal
migration defects53 and a probable cause of impaired fetal
movement, which is consistent with the joint deformities
of the patient at birth. A closer histologic examination of
the cerebellum of 1-d-old Ercc1/ mice revealed hypopla-
sia and simpliﬁed gyri as well (ﬁg. 1E). By day 4, there was
signiﬁcantly less difference between Ercc1/ andwild-type
littermates, which establishes this phenomenon as de-
layed cerebellar development. Remarkably, similar ar-
rested development of the cerebellum was observed in
Xpa/;Csb/ mice,54 which are NER deﬁcient, suggesting
that cells of the cerebellum, including Purkinje cells, must
be particularly vulnerable to DNA damage during devel-
opment. Patient 165TOR demonstrates that impaired
DNA repair compromises embryonic postmitoticneuronal
function in humans as well.
In contrast to the null mice, 165TOR has reduced but
clearly detectable levels of ERCC1-XPF protein and resid-
ual NER and crosslink repair. In fact, these levels are similar
to that of a typical XP-F patient with mild XP without
developmental defects20 and are even higher than those
of an exceptional XP-F case patient with a more severe
mutation that caused growth failure at a juvenile age.23
This discrepancy in phenotype can be interpreted tomean
that ERCC1 and XPF have distinct functions in vivo. How-
ever, on the basis of the similarity of the Ercc1/ and
Xpf/ mouse phenotypes and the requirement for ERCC1
and XPF proteins to stabilize one another in vivo, other
interpretations seem plausible as well. First, processing of
ERCC1/XPF, as seen in cultured ﬁbroblasts here,may differ
in target tissues. Nothing is known about tissue-speciﬁc
ERCC1-XPF levels yet, but known differences in protea-
somic activity could be involved. Second, ERCC1 has been
reported to interact with the TFIIH subunit XPB.55 Failure
of interaction may mimic other genetic defects that cause
severe COFS, such as the TFIIH subunit XPD34 or the TFIIH-
binding NER endonuclease XPG.35,56,57 On the basis of the
severe mouse phenotype, the rarity of a human ERCC1
deﬁciency was attributed to embryonic lethality.24 This is
further supported by the extremely severe phenotype of
patient 165TOR despite residual protein and measurable
DNA repair. Alternatively, the possibility of ERCC1 deﬁ-
ciency in a neonate with growth retardation may be fre-
quently overlooked because sun sensitivity is classically
required for diagnosis of an NER defect.
In conclusion, we identiﬁed the ﬁrst case of human
ERCC1 deﬁciency, resulting in severe embryonic and post-
natal growth failure and COFS, which represents the clin-
ically severest NER deﬁciency published so far and is con-
sistent with mouse models of ERCC1-XPF deﬁciency. The
phenotype is also distinct and more severe than that of
NER deﬁciency alone. This case reveals the importance of
ERCC1-XPF during human fetal development, in partic-
ular for the CNS.
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